Drug Shortage Report for TEVA-TELMISARTAN

Last updated on 2020-09-22 History
Report ID 120256
Drug Identification Number 02320177
Brand name TEVA-TELMISARTAN
Common or Proper name TELMISARTAN 40MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) TELMISARTAN
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100's & P pack 30's
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2020-07-14
Estimated end date 2021-03-31
Actual end date
Shortage status Actual shortage
Updated date 2020-09-22
Company comments Allocation 100% of Teva market from July to Sept 2020
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-09-22 French Compare
v6 2020-09-22 English Compare
v5 2020-09-10 French Compare
v4 2020-09-10 English Compare
v3 2020-07-15 English Compare
v2 2020-07-14 French Compare
v1 2020-07-14 English Compare